Green Square Asset Management »

Regeneron Pharmaceuticals shares owned by Green Square Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Green Square Asset Management from 13F filings

Historical chart of Green Square Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Green Square Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Green Square Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $244k 232 1051.03
2024-03-31 $226k 232 973.80
2023-12-31 $204k 232 878.29

More positions owned by Green Square Asset Management

Ishares S&p 500 Growth Etf Exchange traded fund (IVW)
Zoominfo Technoligies Common stock (ZI)
Spdr S&p 500 Etf Tr Exchange traded fund (SPY)
Apple Common stock (AAPL)
Zions Bancorporation Common stock (ZION)
Amazon.com Common stock (AMZN)
Microsoft Corp Common stock (MSFT)
Broadcom Common stock (AVGO)
Jpmorgan Chase & Co Common stock (JPM)
Meta Platforms Inc Cl A Common stock (META)
Abbvie Common stock (ABBV)
Alphabet Inc Cap Stock Cl A Common stock (GOOGL)
Corning Common stock (GLW)
Texas Instruments Common stock (TXN)
At&t Common stock (T)

View all positions for Green Square Asset Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
Morgan Stanley
T. Rowe Price Associates
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals